Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-07

FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)

View source ↗

Summary

FDA approved a supplemental application for Butrans (buprenorphine) submitted by Purdue Pharma L.P. The approval may involve changes to the product labeling or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTRANS (Buprenorphine)

Snippet

SUPPL AP for BUTRANS (BUPRENORPHINE)